Dharmendra Kumar Aggarwal vs Govt. of NCT of Delhi

Judicial Analysis Court Copy Headnote Facts Arguments Court observation

DELHI HIGH COURT
PRATHIBA M.SINGH
Dharmendra Kumar Aggarwal – Appellant
Versus
Govt. of NCT of Delhi – Respondent

Table of Content
1. availability of tocilizumab for patients (Para 4 , 5 , 6)
2. court's directions on drug supply and information (Para 7 , 8 , 9)
3. affidavit on manufacturing and clinical trials (Para 10 , 11)
4. roche's import status and government licensing stance (Para 12 , 13)
5. observations on the necessity of tocilizumab (Para 15 , 17)
6. inquiry into future supplies and trials (Para 20 , 21)
7. order for follow-up and next hearing (Para 22 , 24 , 25)

JUDGMENT

Prathiba M. Singh, J. (Oral)--This hearing has been done through video conferencing.

CM APPL. 15878/2021(for exemption)

2. Allowed, subject to all just exceptions. Application is disposed of.

CM APPLs. 15879-80/2021(exemption from filing court fee and attested affidavits)

3. These are applications seeking exemption from filing court fee and duly notarized affidavits. Binding the deponent of the affidavit to the contents of the application, the exemption is granted. Insofar as the court fee is concerned, the same be deposited within one week. Applications are disposed of. Registry to submit a report in case the court fees is not filed after a month.

W.P.(C) 5173/2021

4. The present petition is concerned with the supply